No significant association was found between ALDH1A1, CD44, and CD133 expression in tumor cells and the examined clinicopathological features, such as age, residual tumor status, grade, FIGO stage, serum CA125, and response to treatment (Table 2) (Fisher’s exact or Chi-square test as appropriate). This evidence concerns the gene PROM1 and neoplasm.